Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994
The development of a client application for the collaborative social and medical services systemD M Moore, H S Gilson, Y Li, et al.Seminars in Hematology|October 1, 1994
Retinoic acid and interferon in human cancer: mechanistic and clinical studiesD M Moore, D V Kalvakolanu, S M Lippman, et al.HIV Medicine|August 22, 2019
Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural UgandaJ Birungi, Z Cui, S Okoboi, et al.HIV Medicine|February 28, 2015
Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaL Lourenço, H Samji, A Nohpal, et al.Medinfo. MEDINFO|January 1, 1995
A proposed architecture for ambulatory systems developmentG J Buffone, C A Petermann, R B Bobroff, et al.Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994
Collaborative Social and Medical Service SystemC A Petermann, R B Bobroff, D M Moore, et al.Medinfo. MEDINFO|January 1, 1995
Collaborative social and medical service applicationC A Petermann, G J Buffone, R B Bobroff, et al.Science (New York, N.Y.)|December 4, 1981
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swineD G Kleid, D Yansura, B Small, et al.Human Reproduction (Oxford, England)|February 16, 2006
Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation eventsR Harun, L Ruban, M Matin, et al.American Journal of Veterinary Research|March 1, 1985
Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattleP D McKercher, D M Moore, D O Morgan, et al.Pageof 11